Delivering therapeutic RNA into the brain using extracellular vesicles

Area of Science:

• RNA therapeutics
• Neuroscience
• Nanomedicine

Background:

• RNA-based therapies show great promise but face delivery challenges, especially across the blood-brain barrier.
• Conventional delivery methods like lipid nanoparticles are often excluded by the blood-brain barrier and RNA is prone to degradation.
• Extracellular vesicles (EVs) are natural nanoparticles that protect cargo and have emerged as a potential solution for RNA delivery.

Purpose of the Study:

• To review current RNA delivery strategies for brain applications.
• To highlight the challenges associated with conventional RNA delivery methods.
• To emphasize the potential of EV-mediated RNA delivery for neurological disorders.

Main Methods:

• Literature review of RNA delivery strategies.
• Analysis of challenges in crossing the blood-brain barrier.
• Evaluation of extracellular vesicles as RNA carriers.

Main Results:

• Conventional RNA delivery methods face significant hurdles in brain targeting due to the blood-brain barrier.
• Extracellular vesicles demonstrate inherent protection for RNA cargo and efficient cellular uptake.
• EVs show promise for safe and effective delivery of RNA therapeutics to the brain.

Conclusions:

• Extracellular vesicles represent a promising platform for advancing RNA-based therapeutics for neurological disorders.
• Further research into RNA/EV brain delivery strategies is crucial to realize their therapeutic potential.
• EV-mediated delivery offers a viable path to overcome current limitations in treating brain diseases with RNA.